薬理学と薬学化学における多標的薬物に関する最近の洞察

Sadık Hüseyin Cemali¹, Samet Poyraz^1,2, Samet Belveren³

¹Faculty of Pharmacy, Department of Basic Pharmaceutical Sciences, Çukurova University, Balcalı, 01330, Adana, Türkiye.

ChemMedChem

|September 1, 2025

まとめ

マルチターゲットの薬の設計は薬剤耐性に対抗しアルツハイマー病や癌のような複雑な病気を治療する有望なアプローチですこの戦略は治療効果を高めるために同時に複数の標的を攻撃する薬の開発を伴うものです

科学分野:

薬剤化学
薬理学について
薬物の発見

背景:

現在の薬はしばしば"特異性パラダイム"に依存し,耐性を獲得し,有効性を低下させます.
複雑な疾患 (アルツハイマー病,パーキンソン病,がんなど) は複数の遺伝的,環境的要因を伴うため,単一標的アプローチは不十分である.
特殊性パラダイムの限界は新しい治療戦略を必要とします

研究の目的:

マルチターゲットの薬剤設計の方法論を見直す
マルチターゲットの薬の合成経路を探るため
マルチターゲットの薬の発見の応用と最近の進歩について議論する.

主な方法:

既定および新興のマルチターゲットの薬物設計戦略の概要
マルチターゲットの化学反応と合成経路の分析
この分野における最新の研究と事例をまとめています.

主要な成果:

マルチターゲットの薬の開発のための主要な方法と合成アプローチの特定.
マルチターゲットの薬が耐性を克服する可能性を示した.
マルチターゲットの薬の応用性を強調する

結論:

マルチターゲットの薬の設計は薬剤耐性や複雑な病気に対処するために不可欠です
このアプローチは,単一標的薬と比較して,より効果的な治療戦略を提供します.
マルチターゲットの薬の設計に関する研究が継続されれば医学に大きな進歩が期待できます

キーワード:

癌について分子ドッキングマルチターゲットの薬物神経変性疾患合成方法

さらに関連する動画

05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

16.6K

10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.9K

関連する概念動画

01:26

Drug Discovery: Overview

8.7K

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

8.7K

01:26

Targets for Drug Action: Overview

7.4K

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

7.4K

02:57

Targeted Cancer Therapies

7.8K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

7.8K

01:24

Principles of Drug Action

6.6K

Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...

6.6K

01:28

Structure-Activity Relationships and Drug Design

1.0K

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

1.0K

01:27

Combined Effects of Drugs: Synergism

4.7K

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...